The Application dimension of the Drug Testing Software market delineates end‑use environments where the solutions are deployed. Primary sub‑segments include workplace screening, clinical laboratories, forensic laboratories, rehabilitation centers, sports anti‑doping programs, and government agencies. Workplace screening, which encompasses pre‑employment, random, and post‑incident testing, accounts for the largest share, reflecting the broad regulatory mandate across industries. Clinical laboratories contribute a substantial portion due to high‑throughput assay integration and compliance reporting. Forensic laboratories, though niche, drive premium pricing because of evidentiary standards. Rehabilitation centers leverage software for longitudinal monitoring and relapse prevention, while sports anti‑doping and government agencies add specialized analytical layers for compliance and public safety. Collectively, these application categories shape the overall market size, with each segment’s revenue proportion directly tied to the volume of tests processed and the regulatory intensity of the sector. This granular view underpins the broader Drug Testing Software segmentation framework used by analysts.